Mountcastle David 4

What Happened

• David Mountcastle, Chief Financial Officer of Privia Health Group, received a total of 77,919 shares in early March 2026. On 2026-03-10 he was granted 35,335 restricted stock units (RSUs) and on 2026-03-11 he received 42,584 shares from vested performance stock units (PSUs). Both transactions show an acquisition price of $0.00 (awards/vests), so no cash was paid by the reporting person.

Key Details

• Transaction dates and prices:
  • 2026-03-10: Grant of 35,335 RSUs @ $0.00 (Footnote F1)
  • 2026-03-11: Vesting/distribution of 42,584 shares from PSUs @ $0.00 (Footnote F2)
• Total shares acquired: 77,919 shares (combined)
• Shares owned after transaction: Not specified in the provided filing
• Notable footnotes:
  • F1: RSUs granted under the 2021 Omnibus Incentive Plan; they vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service.
  • F2: Vesting and distribution of 42,584 shares underlying PSUs granted May 9, 2023 for the 2023–2025 performance period.
• Filing timeliness: Form 4 was filed on 2026-03-12 for transactions on 2026-03-10 and 2026-03-11; this appears to be timely.

Context

• RSUs are time-based awards that convert to shares as they vest; PSUs are performance-based and only convert to shares if preset performance goals are met for the performance period. These transactions are awards/vests (not open-market purchases or sales) and therefore reflect compensation vesting rather than an active buy or sell decision.